In Q4 FY2026 Divi's Laboratories reported consolidated Total Income of ₹2,986 Cr and Revenue from operations of ₹2,831 Cr, up from ₹2,671 Cr and ₹2,585 Cr respectively in Q4 FY2025. Profit after tax for the quarter was ₹751 Cr versus ₹662 Cr in Q4 FY2025, supported by a forex gain of ₹90 Cr in the quarter. Cost of materials consumed rose to ₹1,214 Cr in Q4 FY2026, increasing total expenses to ₹2,023 Cr, while the board recommended a final dividend of ₹30 per share for FY2025-26. Management flagged the statutory impact of the new Labour Codes (recognised as an exceptional item of ₹74 Cr in the...
